Hyperkalemia is a potentially life-threatening condition predominantly seen in patients treated with renin-angiotensin-aldosterone system ( RAAS ) inhibitors with stage 3 or greater chronic kidney disease ( CKD ) who may also have diabetes , heart failure , or both .